Khan, Mehnaz <br/><br/>
Characterization and pharmacologic targeting of EZH2, a fetal retinal protein and epigenetic regulator, in human retinoblastoma.  [electronic resource] 

 -  Laboratory investigation; a journal of technical methods and pathology  Nov 2015 
 - 1278-90 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1530-0307 
<br/><br/><label>Standard No.: </label>10.1038/labinvest.2015.104  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Line, Tumor<br/>Child, Preschool<br/>Enhancer of Zeste Homolog 2 Protein<br/>Epigenesis, Genetic--physiology<br/>Female<br/>Humans<br/>Infant<br/>Male<br/>Mice<br/>Polycomb Repressive Complex 2--drug effects<br/>Retinal Neoplasms--metabolism<br/>Retinoblastoma--metabolism